|
Caredx Inc (NASDAQ: CDNA) |
|
Caredx Inc
CDNA's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Caredx Inc growth rates, revenue grew
by 23.35 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 1857
Medical Laboratories industry recorded
growth of revenues by 6.58 %
Caredx Inc net loss decreased from $-23 millions, to $-7 millions in III. Quarter 2024,
• More on CDNA's Growth
|
|
Caredx Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 61.02 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
-0 |
PE TTM
|
|
Company's Price to Sales ratio is at 3.79.
Medical Laboratories industry's Price to Sales ratio is at 2.54.
• More on CDNA's Valuation
|
|
|
|
|
Caredx Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 61.02 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
-0 |
PE TTM
|
|
Company's Price to Sales ratio is at 3.79.
Medical Laboratories industry's Price to Sales ratio is at 2.54.
Caredx Inc Price to Book Ratio is at 4.34 lower than Industry Avg. of 29.03. and higher than S&P 500 Avg. of 0.02
• More on CDNA's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com